About Priyanka Mandal
Priyanka is a passionate investment analyst and commentator. After earning a master's degree in economics, her interest in financial markets motivated her to begin her career in investment research.
Her approach is to find a financial instruments’ intrinsic value for predicting its future price movement.
Recent Articles By Priyanka Mandal
Grab These 3 Mid-Cap Software Stocks on the Dip
Continuing remote and hybrid working due partly to the emergence of the COVID-19 omicron variant and to the need for improved productivity have accelerated the adoption of software solutions. In addition, rapid digitalization is expected to accelerate the software industry's growth. Therefore, we believe recent price dips offer an excellent opportunity to bet on fundamentally sound mid-cap software technology stocks Endava (DAVA), Amdocs (DOX), and Datto (MSP). Read on.
3 Dividend-Paying Chip Stocks That are Rated 'Strong Buy' in the POWR Ratings
The continuing global semiconductor chip shortage has hampered production in various sectors. However, President Biden’s efforts to address the crisis and rising demand from several industries should propel the chip industry’s growth. Therefore, we think dividend-paying chip stocks Broadcom (AVGO), Intel (INTC), and United Microelectronics (UMC) could be ideal bets now. Also, these stocks are rated Strong Buy in our proprietary POWR Ratings system. So, let’s discuss these names.
2 Popular Tech Stocks That Recently Plunged More Than 45%
Technology stocks were in relief-rally mode last week and drove the markets higher. However, concerns about the Fed's decision to increase interest rates, high inflation, and the discovery of the COVID-19 omicron variant could end the tech stock party next year. Therefore, we believe investors should be cautious about betting on popular tech stocks DocuSign (DOCU) and Asana (ASAN), which have both lost more than 45% in price over the past month. Let’s discuss.
Think the Market is Going to Crash? Then Buy These 4 Inverse ETFs
Concerns surrounding the spread of COVID-19 omicron variant, high inflation, and the Fed's decision to speed up its tapering of asset purchases could precipitate a market crash in the near term. So, to hedge one’s portfolio against a potential correction, we think inverse ETFs ProShares Short S&P500 (SH), ProShares Short QQQ (PSQ), ProShares Short Russell2000 (RWM), and ProShares Short Dow30 (DOG) could be ideal bets now. Read on.
Forget Aurora Cannabis, Buy These 3 Pot Stocks Instead
The increasing legalization of cannabis in the United States and the rising popularity of cannabis products for therapeutic and recreational uses have propelled the cannabis market’s growth. However, our view is that Aurora Cannabis (ACB) doesn’t look fundamentally fit enough to capitalize on the industry’s trend. So, instead, we think it could be worth betting on fundamentally sound pot companies Curaleaf (CURLF), Tilray (TLRY), and HEXO (HEXO). We think they could potentially deliver promising returns in the coming months. Let’s discuss.
3 A-Rated Large-Cap Chip Stocks to Own for the Long Term
The semiconductor chip shortage has hurt production across industries around the globe. However, the Biden Administration’s push to pass a spending bill to boost U.S. chip production should address the crisis to a great extent. And because the semiconductor industry is expected to continue thriving on rising demand, we think it could be wise to invest in fundamentally sound large-cap chip stocks Intel (INTC), Micron (MU), and United Microelectronics (UMC). These stocks are rated A (Strong Buy) in our proprietary rating system.
2 Medical Device Stocks Wall Street Predicts Will Rally 35% or More
The medical devices industry is expected to grow significantly in the coming months due to an uptick in demand for devices for essential and elective surgeries. Furthermore, technological advances and the adoption of IoMT and metaverse should propel the medical device industry’s growth. Therefore, Wall Street analysts expect medical device stocks Boston Scientific (BSX) and Zimmer Biomet (ZBH) to gain substantially in the upcoming months.
4 Low-Beta Stocks to Buy for a Volatile Market
Global economic uncertainty, inflationary pressure, a disappointing jobs report, and concerns around the COVID-19 omicron variant are fostering stock market volatility. So, against this backdrop, we think it would be wise to bet on low-beta stocks Regeneron (REGN), ResMed (RMD), Ericsson (ERIC), and Canon (CAJ). We think they could provide stable returns in the current environment. Read on to learn more.
2 Fertilizer Stocks to Buy on the Dip
Tight supply and surging energy costs caused fertilizer prices to soar last month. Furthermore, advanced farming techniques and the increasing use of bio-fertilizers are driving the growth of the fertilizer industry. Therefore, we believe recent price dips could be an opportune time to bet on fundamentally sound fertilizer stocks CVR Partners (UAN) and Intrepid (IPI). Read on.